10th Biennial Helene Harris Memorial Trust meeting.
Improving the prognosis of ovarian cancer patients is a major challenge to scientists and clinicians. At a recent multidisciplinary meeting in Washington DC, advances in identification of precursor lesions, progress in disease biomarkers and animal models, the promise of nanotechnology, and strategies for manipulation of the innate and adaptive immune response offered prospects for real progress in this difficult-to-treat disease.
Barts and The London Queen Mary's School of Medicine and Dentistry, UK.
Frances R
FR
Balkwill
Alan
A
Ashworth
Robert C
RC
Bast
Jonathon S
JS
Berek
Jeff
J
Boyd
Mary L
ML
Disis
Hani
H
Gabra
Martin E
ME
Gore
Thomas C
TC
Hamilton
Ian J
IJ
Jacobs
Stan B
SB
Kaye
Elise C
EC
Kohn
Gordon B
GB
Mills
Nicole D
ND
Urban
D000818:Animals; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000175:diagnosis* / Q000276:immunology / Q000628:therapy*